Dr. Zebayel Akele Baye, MD

Dr. Baye practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Baye's NPI, 1093988628, was assigned on April 3, 2008. Dr. Baye graduated from Jimma University College of Public Health and Medical Sciences in 1992. Dr. Baye holds California license A115627.

Dr. Baye's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Baye's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Baye is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Indio Community Health Center. Dmand AI also links Dr. Baye to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baye practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Baye's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Baye is board certified in internal medicine by the American Board of Internal Medicine. Dr. Baye is licensed in California.

Dmand AI lists acute diabetes, cardiac arrhythmia, congestive heart failure, electrolyte disorders, gastrointestinal bleeding, sepsis, stroke and urinary tract infection among the conditions Dr. Baye treats.

CMS data shows 341 Medicare services from Dr. Baye across 5 procedure codes in 2024, for 126 Medicare patients. Medicare paid $30,581 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Baye in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 79% are also on Medicaid. Their average risk score is 3.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baye's median patient age at 58, with 46% women.

In 2024, Dr. Baye wrote 213 Medicare Part D claims for 82 patients. 84% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $573 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Baye for performance year 2024, reported as part of a group. Dr. Baye accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Baye graduated from Jimma University College of Public Health and Medical Sciences in 1992.

Dr. Baye is in network with 3 carriers, including Aetna, Molina and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.